Summary
Danaher Corporation (DHR) filed an 8-K on January 7, 2019, to provide a preview of its anticipated financial performance for the fourth quarter of 2018. This update was issued in advance of a presentation at the J.P. Morgan Healthcare Conference. The filing incorporates by reference a press release that offers insights into the company's operational and financial condition ahead of its full fourth-quarter earnings report. Investors should note that this information is provided for informational purposes and is not considered "filed" for certain regulatory purposes, meaning it doesn't automatically update previous filings under the Exchange Act, unless specifically referenced. While the 8-K itself is brief, it signals Danaher's proactive communication regarding its year-end results. The key takeaway for investors is the anticipation of updated financial metrics and operational commentary that will be discussed at the J.P. Morgan Healthcare Conference. This allows investors to gain a preliminary understanding of the company's recent performance and potential outlook before the official earnings release, enabling more informed investment decisions.
Key Highlights
- 1Danaher Corporation (DHR) issued an 8-K filing on January 7, 2019, related to its anticipated Q4 2018 financial performance.
- 2The filing references a press release issued on the same date, which contains the detailed financial information.
- 3The information was shared in advance of Danaher's presentation at the J.P. Morgan Healthcare Conference on January 8, 2019.
- 4The press release provides commentary on the Company's Results of Operations and Financial Condition.
- 5The filing includes Exhibit 99.1, the press release titled 'Danaher CEO to Comment on Financial Performance'.
- 6This disclosure serves as a preliminary update to investors regarding year-end financial expectations.
- 7The information is not deemed 'filed' under Section 18 of the Exchange Act or incorporated by reference into other filings unless specifically stated.